CULVER CITY, Calif. & LAS VEGAS--(BUSINESS WIRE)--NantHealth (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, will be exhibiting this year at the Healthcare Information & Management Systems Society Annual Conference & Exhibition 2018 (HIMSS18) taking place March 5-9 at the Venetian – Palazzo – Sands Expo Center in Las Vegas, NV at booth #14003.
NantHealth will be presenting “The Future of Device Connectivity Across the Continuum of Care” in the Population Health Solutions Lab, Session SL20, on Wednesday, March 7, 2018 at 10:30 AM Pacific Time. Presenter Wesley Madden BSN RN, VP of Connectivity Sales, will highlight NantHealth’s Connected Care solutions today, what the future holds for products in this category, and how this technology has the potential to dramatically improve care delivery, clinician satisfaction, and cost reduction efforts.
In addition, NantHealth representatives will be exhibiting Connected Care, a portfolio of medical device integration (MDI) products that include:
- DeviceConX™ – The award-winning, software-based, and vendor-agnostic Medical Device Data System (MDDS) trusted by hospitals and clinics across the globe to facilitate the integration of hundreds of medical devices with a variety of clinical system endpoints (including popular EHRs).
- VitalsConX – A touch-optimized tablet application that streamlines low-acuity rounding and assessment workflows by eliminating transcription, accelerating data availability, and collecting both device data and observations at the bedside and sending them to the EHR in near real-time.
- HBox® – An IEC60601-compliant fanless PC appliance that acts as hub to capture and relay medical device data from hospital, ambulatory, or home settings.
“As patient needs are shaping the future of healthcare, technology continues to play an integral role in supporting this shift,” said Wesley Madden. “The Connected Care solutions NantHealth is showcasing at HIMSS 2018 integrate medical device data into clinical records and are proven to have an impact on length of hospital overstays, costly medical errors, provider dissatisfaction, and suboptimal patient care.”
Visit NantHealth at booth #14003 in the Population Health Solutions Lab to see a Connected Care demonstration. or attend the presentation in the Population Health Solutions Lab. To schedule a private meeting with a sales, product, or marketing representative please enter your information here.
Cautionary Note Concerning Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, among others, statements regarding the capabilities and anticipated utility of our GPS Cancer, including predicting patient response and resistance to therapeutics, enabling diagnoses by physicians and accelerating efforts to bring novel combinations of therapeutic agents to cancer patients. Forward-looking statements are subject to numerous risks and uncertainties that could cause actual results to differ materially from currently anticipated results. Factors that may cause future results to differ materially from management’s current expectations include, among other things, that GPS Cancer may not perform as anticipated, that sufficient physicians may not adopt GPS Cancer to assist their diagnoses or that healthcare payers may not provide reimbursement for GPS Cancer as expected. Our business is subject to numerous additional risks and uncertainties, including, among others, risks relating to market acceptance of our products; our ability to successfully launch new products and applications; competition; our sales, marketing and distribution capabilities; our planned sales, marketing, and research and development activities; unanticipated increases in costs or expenses; and risks associated with international operations. Information on these and additional risks, uncertainties, and other information affecting our business and operating results can be found in our existing and future filings with the Securities and Exchange Commission. These forward-looking statements speak only as of the date hereof. We disclaim any obligation to update these forward-looking statements except as may be required by law.
About NantHealth, Inc.
NantHealth, Inc., a member of the NantWorks ecosystem of companies, is a next-generation, evidence-based, personalized healthcare company enabling improved patient outcomes and more effective treatment decisions for critical illnesses. NantHealth's unique systems-based approach to personalized healthcare applies novel diagnostics tailored to the specific molecular profiles of patient tissues and integrates this molecular data in a clinical setting with large-scale, real-time biometric signal and phenotypic data to track patient outcomes and deliver precision medicine. For nearly a decade, NantHealth has developed an adaptive learning system, which includes its unique software, middleware and hardware systems infrastructure that collects, indexes, analyzes and interprets billions of molecular, clinical, operational and financial data points derived from novel and traditional sources, continuously improves decision-making and further optimizes our clinical pathways and decision algorithms over time. For more information please visit www.nanthealth.com and follow Dr. Soon-Shiong on Twitter @DrPatSoonShiong.